Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)

Metwally Mohamed A. Hassan; Frederiksen Katrine Diemer; Overgaard Jens

首页> 外文期刊>Acta oncologica. >Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)

【24h】

Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)

机译：低氧放射增敏剂尼莫拉唑治疗头颈部鳞状细胞癌（HNSCC）的依从性和毒性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose. To evaluate the compliance and toxicity of the hypoxic radiosensitizer nimorazole in head and neck cancer patients.

机译：目的。评估缺氧放射增敏剂尼莫拉唑在头颈癌患者中的依从性和毒性。

著录项

来源
《Acta oncologica.》 |2014年第10期|共8页
作者
Metwally Mohamed A. Hassan; Frederiksen Katrine Diemer; Overgaard Jens;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC) [J] . Metwally Mohamed A. Hassan, Frederiksen Katrine Diemer, Overgaard Jens Acta oncologica. . 2014,第1a10期

机译：低氧放射增敏剂尼莫拉唑治疗头颈部鳞状细胞癌（HNSCC）的依从性和毒性
2. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma [J] . Metwally Mohamed A. Hassan, Ali Rubina, Kuddu Maire, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2015,第1期

机译：IAEA-HypoX。低氧放射增敏剂尼莫拉唑与加速放疗在头颈部鳞状细胞癌中的随机多中心研究
3. A Prospective Analysis of Ototoxicity in Modern Radiation Therapy Treatments for Head and Neck Squamous Cell Carcinoma (HNSCC) Patients Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Tri-weekly Cisplatin (Cis) [J] . Blakaj D. M., Custer A., Zoller W., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：具有每周或三周的伴随化疗（CRT）的头颈鳞状细胞癌（HNSCC）患者的现代放射治疗治疗耳毒性前瞻性分析
4. Intelligent analysis of methylation data in Head and Neck Squamous Cell Carcinoma (HNSCC) interactomes [C] . Saad Zaheer, Sabaoon Zeb, Faisal F. Khan International Conference on Artificial Intelligence . 2021

机译：头颈鳞状细胞癌（HNSCC）椎间囊组致甲基化数据智能分析
5. Expression of MT1-MMP in Head and Neck Squamous Cell Carcinomas (HNSCCs) and Endothelial Cells is Regulated by Hypoxia and Semaphorin 4D (Sema4D). [D] . Bugshan, Amr. 2016

机译：低氧和Semaphorin 4D（Sema4D）调节头颈部鳞状细胞癌（HNSCC）和内皮细胞中MT1-MMP的表达。
6. MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation [O] . Lisa Pei Chu, Debra Franck, Christine A. Parachoniak, 2019

机译：头颈部鳞状细胞癌（HNSCC）中的MET基因组改变：新型MET R1004G突变的HNSCC患者对克唑替尼的快速反应
7. Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC) [O] . Metwally, Mohamed Ahmed Hassan, Frederiksen, Katrine Diemer, Overgaard, Jens 2014

机译：缺氧放射增敏剂尼莫拉唑治疗头颈部鳞状细胞癌（HNSCC）的依从性和毒性

Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)

摘要

著录项

相似文献

相关主题

期刊订阅